-
Something wrong with this record ?
Differential requirements for Smarca5 expression during hematopoietic stem cell commitment
T. Turkova, J. Kokavec, T. Zikmund, N. Dibus, K. Pimkova, D. Nemec, M. Holeckova, L. Ruskova, R. Sedlacek, L. Cermak, T. Stopka
Language English Country England, Great Britain
Document type Journal Article
Grant support
24-10435S, 24-10353S
Grantová Agentura České Republiky (Grant Agency of the Czech Republic)
NU21-08-00312, NU22-05-00374
Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
LX22NPO5102, SVV 260637, UNCE/MED/016, COOPERATIO
Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
CZ.02.1.01/0.0/0.0/16_013/0001789, CZ.02.1.01/0.0/0.0/18_046/0015861
Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
NLK
Directory of Open Access Journals
from 2018
Nature Open Access
from 2018-12-01
PubMed Central
from 2018
Europe PubMed Central
from 2018
ProQuest Central
from 2018-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2018
Springer Nature OA/Free Journals
from 2018-12-01
- MeSH
- Adenosine Triphosphatases metabolism MeSH
- Cell Differentiation genetics MeSH
- Hematopoietic Stem Cells * metabolism MeSH
- Hematopoiesis * genetics MeSH
- Mice MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The formation of hematopoietic cells relies on the chromatin remodeling activities of ISWI ATPase SMARCA5 (SNF2H) and its complexes. The Smarca5 null and conditional alleles have been used to study its functions in embryonic and organ development in mice. These mouse model phenotypes vary from embryonic lethality of constitutive knockout to less severe phenotypes observed in tissue-specific Smarca5 deletions, e.g., in the hematopoietic system. Here we show that, in a gene dosage-dependent manner, the hypomorphic allele of SMARCA5 (S5tg) can rescue not only the developmental arrest in hematopoiesis in the hCD2iCre model but also the lethal phenotypes associated with constitutive Smarca5 deletion or Vav1iCre-driven conditional knockout in hematopoietic progenitor cells. Interestingly, the latter model also provided evidence for the role of SMARCA5 expression level in hematopoietic stem cells, as the Vav1iCre S5tg animals accumulate stem and progenitor cells. Furthermore, their hematopoietic stem cells exhibited impaired lymphoid lineage entry and differentiation. This observation contrasts with the myeloid lineage which is developing without significant disturbances. Our findings indicate that animals with low expression of SMARCA5 exhibit normal embryonic development with altered lymphoid entry within the hematopoietic stem cell compartment.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007031
- 003
- CZ-PrNML
- 005
- 20240423155654.0
- 007
- ta
- 008
- 240412s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s42003-024-05917-z $2 doi
- 035 __
- $a (PubMed)38424235
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Turkova, Tereza $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0000000253291812
- 245 10
- $a Differential requirements for Smarca5 expression during hematopoietic stem cell commitment / $c T. Turkova, J. Kokavec, T. Zikmund, N. Dibus, K. Pimkova, D. Nemec, M. Holeckova, L. Ruskova, R. Sedlacek, L. Cermak, T. Stopka
- 520 9_
- $a The formation of hematopoietic cells relies on the chromatin remodeling activities of ISWI ATPase SMARCA5 (SNF2H) and its complexes. The Smarca5 null and conditional alleles have been used to study its functions in embryonic and organ development in mice. These mouse model phenotypes vary from embryonic lethality of constitutive knockout to less severe phenotypes observed in tissue-specific Smarca5 deletions, e.g., in the hematopoietic system. Here we show that, in a gene dosage-dependent manner, the hypomorphic allele of SMARCA5 (S5tg) can rescue not only the developmental arrest in hematopoiesis in the hCD2iCre model but also the lethal phenotypes associated with constitutive Smarca5 deletion or Vav1iCre-driven conditional knockout in hematopoietic progenitor cells. Interestingly, the latter model also provided evidence for the role of SMARCA5 expression level in hematopoietic stem cells, as the Vav1iCre S5tg animals accumulate stem and progenitor cells. Furthermore, their hematopoietic stem cells exhibited impaired lymphoid lineage entry and differentiation. This observation contrasts with the myeloid lineage which is developing without significant disturbances. Our findings indicate that animals with low expression of SMARCA5 exhibit normal embryonic development with altered lymphoid entry within the hematopoietic stem cell compartment.
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a hematopoetické kmenové buňky $x metabolismus $7 D006412
- 650 12
- $a hematopoéza $x genetika $7 D006410
- 650 _2
- $a buněčná diferenciace $x genetika $7 D002454
- 650 _2
- $a adenosintrifosfatasy $x metabolismus $7 D000251
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kokavec, Juraj $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0000000302674570
- 700 1_
- $a Zikmund, Tomas $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0000000324523749
- 700 1_
- $a Dibus, Nikol $u Laboratory of Cancer Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/000000032743352X
- 700 1_
- $a Pimkova, Kristyna $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0000000280333651
- 700 1_
- $a Nemec, Dusan $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0009000436249745
- 700 1_
- $a Holeckova, Marketa $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic
- 700 1_
- $a Ruskova, Livia $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic
- 700 1_
- $a Sedlacek, Radislav $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic $1 https://orcid.org/000000023352392X $7 xx0140532
- 700 1_
- $a Cermak, Lukas $u Laboratory of Cancer Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic. lukas.cermak@img.cas.cz $1 https://orcid.org/0000000287773692 $7 xx0140314
- 700 1_
- $a Stopka, Tomas $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic. tstopka@lf1.cuni.cz $1 https://orcid.org/0000000172366894 $7 xx0101300
- 773 0_
- $w MED00197237 $t Communications biology $x 2399-3642 $g Roč. 7, č. 1 (2024), s. 244
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38424235 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155650 $b ABA008
- 999 __
- $a ok $b bmc $g 2081188 $s 1216798
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 7 $c 1 $d 244 $e 20240229 $i 2399-3642 $m Communications biology $n Commun Biol $x MED00197237
- GRA __
- $a 24-10435S, 24-10353S $p Grantová Agentura České Republiky (Grant Agency of the Czech Republic)
- GRA __
- $a NU21-08-00312, NU22-05-00374 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
- GRA __
- $a LX22NPO5102, SVV 260637, UNCE/MED/016, COOPERATIO $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_013/0001789, CZ.02.1.01/0.0/0.0/18_046/0015861 $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
- LZP __
- $a Pubmed-20240412